Skip to main content


Xenoport's cost-cutting tactics lead to buyout with hefty premium

The biotechnology company, which makes alcoholism drug Horizant, was acquired by privately held Arbor Pharmaceuticals for $467 million in cash, a price lower than at least one analyst expected.

Here's Why XenoPort (XNPT) Stock is Continuing to Surge Today

XenoPort (XNPT) shares are soaring Monday as Arbor Pharmaceuticals agreed to acquire the company in a deal valued at about $467 million.

XenoPort (XNPT) Stock Skyrockets, Arbor Pharmaceuticals Acquiring For $467 Million

XenoPort (XNPT) shares are soaring Monday on the announcement that Arbor Pharmaceuticals will buy the biopharmaceutical company in a deal valued at about$467 million.

5 stocks insiders love right now

Insiders at these companies have been scooping up shares of their own stock lately.

XenoPort (XNPT) Stock Advancing on Potential Sale

XenoPort (XNPT) stock is gaining on Friday morning as the company explores the possibility of selling its self.

Breaking News

Dr. Doom Sees Plenty of Gloom: Roubini's Bearish Musings

He predicts a global economic and financial crisis, sparked by a debt bubble and accompanied by stagflation.

Carvana, the Amazon of Used Cars, Is Collapsing

The Amazon of used cars lost a third of its market value on Wednesday and payment deadlines loom.

Ford Gets a Big Win

The Dearborn, Mich., auto veteran is ramping up initiatives in the race to play a leading role in electric vehicles.